Glioma Program | Overview

LIke ThisLIke ThisLIke ThisLIke ThisLIke This

Contact the Glioma Program

The Glioma Program at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center treats a wide range of high-grade and low-grade gliomas, including diffuse intrinsic pontine gliomas, optic pathway gliomas, cerebellar low-grade astrocytomas, glioblastoma multiforme, and anaplastic astrocytomas.  As one of the most highly funded brain tumor programs in the world, children who come to our program have access to unique clinical trials, in which they can receive the most recent gliomas treatments.

Dana-Farber/Boston Children’s is an integrated pediatric hematology and oncology partnership between Dana-Farber Cancer Institute and Boston Children’s Hospital. We offer, in one specialized program, the full spectrum of services that are needed for diagnosis, treatment and ongoing care of even the rarest and hard-to-treat conditions.

Treatment teams in the Glioma Program feature neuro-oncologists who are experts at treating gliomas. In addition, our team includes internationally recognized pediatric subspecialists, including neurologists, neurosurgeons and radiation oncologists.

Learn more about our Glioma Program on the Dana-Farber/Boston Children’s website.

We are grateful to have been ranked #1 on U.S. News & World Report's list of the best children's hospitals in the nation for the third year in a row, an honor we could not have achieved without the patients and families who inspire us to do our very best for them. Thanks to you, Boston Children's is a place where we can write the greatest children's stories ever told.”
- Sandra L. Fenwick, President and CEO

Boston Children's Hospital
300 Longwood Avenue, Boston, MA 02115
For Patients: 617-355-6000
For Referring Providers: 844-BCH-PEDS | 844-224-7337